Prev Close $5.75 Avg Vol (3M) 2,673,608 Market Cap 380.24M Dividend & Yield -- 52-Week Range $3.40 - $9.46 P/E (TTM) -- EPS (TTM) -$1.06690 

7374

Mkt Cap: 370.09M. P/E Ratio: —. Div/Yield: 0.00 The listed name for PRQR is ProQR Therapeutics N.V. Ordinary Shares. Show More. CEO: Daniel Anton de 

Ocular Therapeutix has a consensus price target of $24.80, indicating a potential upside of 62.73%. Given ProQR Therapeutics' higher probable upside, analysts plainly believe ProQR Therapeutics is more favorable than Ocular Therapeutix. ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. The company's main product candidates are QR-010, QR-110, and QR-313. View Proqr Therapeutics N.v. PRQR investment & stock information.

Proqr market cap

  1. Ies järfälla
  2. Hur länge får en 16 åring jobba på restaurang
  3. Avdrag resor till och från arbetet uträkning
  4. Historisk materialism karl marx
  5. Freddys bar & restaurang södertälje
  6. Josef frank underlägg
  7. Övervintring pelargon
  8. Troll vagga
  9. It drifttekniker flashback

Earnings: 7-May (Est.) Company Event: 7-Oct. Change Benchmark Symbol:. View Proqr Therapeutics N.V. - (PRQR) stock price and volume charts for most recent trading day, 5-day, 1-month and longer monthly Market Cap: 380.2 M. All information about ProQR Therapeutics: stock price ProQR Therapeutics, quote chart ProQR Therapeutics, company dividends ProQR Therapeutics, company news. High performance interface for global bond market screening; Full informati Market Closed. After Hours: $6.40 0.21 | 3.39% Market Cap. 409.3316 Mil Business Description. ProQR Therapeutics NV is a biopharmaceutical company.

ProQR Therapeutics market cap is $219.1 m.. View ProQR Therapeutics stock / share price, financial statements, key ratios and more at Craft. ProQR Therapeutics N.V (PRQR) stock price is $7.82, market value is $392601614 and P/E ratio is null ProQR Therapeutics N.V. - Ordin Stock Price, Chart, Latest News, Technical Indicator and other information Market Cap $396,767,322.

Instantly find out the ProQR Therapeutics NV stock quote PRQR Stock Price, ProQR Therapeutics NV Stock Quote (NASDAQ) | CoinCodex Total Market Cap: M. Cap: $ 1.84T (-10.6%)

2020-08-29 · ProQR Therapeutics N.V.: ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares Mar 30, 2021 ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares Learn more about ProQR at www.proqr.com. ProQR Therapeutics N.V. Investor Contact:Sarah KielyProQR Therapeutics N.V.T: +1 617 599 6228skiely@proqr.comorHans VitzthumLifeSci AdvisorsT: +1 617 430 Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.

Proqr market cap

2021-04-23

Range.

Proqr market cap

Find ProQR's latest press releases here and subscribe to get email alerts every time news is released. The company's market cap stands at $234.0 million. Rezolute (NASDAQ: RZLT ) shares declined by 11.22% to $6.65. Rezolute's stock is trading at a volume of 8.9K shares as of 12:32 EST. Market Cap (Millions) USD 306.428: Total Shares Outstanding (Millions) 23.34: Latest Filing Dates: Annual December 31, 2014: Semi Annual December 31, 2014: Quarterly June 30, 2015: Next Release Date November 23, 2015: Filing Currency USD: Listed Exchange NASDAQ Find the latest ProQR Therapeutics N.V. (PRQR) stock quote, history, news and other vital information to help you with your stock trading and investing. Latest news headlines for Proqr Therapeutics with market analysis and analyst commentary.
Bazaar sävsjö

Year 2020 2019 2018 2017 2016 2015 2014; Market Capitalization Market Capitalization Definition Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding.

For the last 5 trading sessions, its performance is down -8.11% and up 10.51% for month. 2021-04-22 · Real time ProQR Therapeutics (PRQR) stock price quote, stock graph, news & analysis. ProQR Therapeutics B.V., a biopharmaceutical company, is engaged in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders.
Annika elmer

brussel airlines news
plantagen stockholm nacka
combi parts
undersköterska utbildning utan betyg
arbetsformedlingen blankett

2021-04-22

Sepofarsen (CEP290 LCA10) QR-421a (USH2A RP) QR-1123 (RHO RP) Presentations & Publications; RNA therapy. Axiomer technology; Patients & Community.


Försena engelska
vad tjänar en uber förare

Market Cap $:. 388.83 Mil. Enterprise Value $:. 337.61 Mil. PE Ratio: 0.00. PB Ratio: 4.24. Warning! GuruFocus has detected 2 Severe warning signs with PRQR.

ProQR Therapeutics market cap is $219.1 m.. View ProQR Therapeutics stock / share price, financial statements, key ratios and more at Craft. ProQR Therapeutics N.V (PRQR) stock price is $7.82, market value is $392601614 and P/E ratio is null ProQR Therapeutics N.V. - Ordin Stock Price, Chart, Latest News, Technical Indicator and other information Market Cap $396,767,322. April 13, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N The proposed offering is subject to market conditions and other Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares. It is computed by multiplying the market price by the number of outstanding shares. For example, a publicly held company with 10 million shares outstanding that trade at $10 each would have a market capitalization of $100 million.

With a market capitalization of US$233m, ProQR Therapeutics is a small cap stock, so it might not be well known by many institutional investors. Our analysis of the ownership of the company, below, shows that institutions own shares in the company.

ProQR Therapeutics NV is a biopharmaceutical company. Prev Close $5.75 Avg Vol (3M) 2,673,608 Market Cap 380.24M Dividend & Yield -- 52-Week Range $3.40 - $9.46 P/E (TTM) -- EPS (TTM) -$1.06690  Mkt Cap: 370.09M. P/E Ratio: —. Div/Yield: 0.00 The listed name for PRQR is ProQR Therapeutics N.V. Ordinary Shares. Show More.

And to visit ProQR Therapeutics NV's official web site, go to www.proqr.com. Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares. It is computed by multiplying the market price by the number of outstanding shares.